Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE (Details 1)

v3.21.2
NOTES PAYABLE (Details 1)
$ / shares in Units, $ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2021
USD ($)
Equity_Instrument
$ / shares
Dec. 31, 2020
USD ($)
Equity_Instrument
$ / shares
Feb. 21, 2020
Debt Instrument [Line Items]      
Interest rate     10.00%
Principal Outstanding $ 22,531 $ 15,294  
Unamortized Discount 5,114 1,720  
Carrying Amount $ 17,417 $ 13,574  
Shares Underlying Notes | Equity_Instrument 10,172,962 3,946,723  
Convertible notes payable, Non-current $ 12,526 $ 3,150  
2018 Convertible Notes Payable [Member]      
Debt Instrument [Line Items]      
Interest rate   10.00%  
Term of Notes   2 years  
Conversion Price | $ / shares [1]   $ 10.00  
Principal Outstanding   $ 3,150  
Carrying Amount   $ 3,150  
Shares Underlying Notes | Equity_Instrument   316,723  
2021 Convertible Notes Payable [Member]      
Debt Instrument [Line Items]      
Interest rate 2.00%    
Term of Notes 3 years    
Conversion Price | $ / shares [2] $ 1.48    
Principal Outstanding $ 14,490    
Unamortized Discount 5,114    
Carrying Amount $ 9,376    
Shares Underlying Notes | Equity_Instrument 9,856,378    
Convertible Notes Payable [Member]      
Debt Instrument [Line Items]      
Principal Outstanding $ 17,640 $ 3,150  
Unamortized Discount 5,114    
Carrying Amount $ 12,526 $ 3,150  
Shares Underlying Notes | Equity_Instrument 10,172,962 316,723  
Principal Outstanding, Non Current $ 17,640    
Unamortized Discount, Non Current 5,114    
Convertible notes payable, Non-current $ 12,526    
Shares Underlying Notes, Non Current | Equity_Instrument 10,172,962    
Principal Outstanding, Current   $ 3,150  
Convertible notes payable, Current   $ 3,150  
Shares Underlying Notes, Current | Equity_Instrument   316,723  
2020 Convertible Notes Payable [Member]      
Debt Instrument [Line Items]      
Interest rate 12.00%    
Term of Notes 3 years    
Conversion Price | $ / shares [1] $ 10.00    
Principal Outstanding $ 3,150    
Carrying Amount $ 3,150    
Shares Underlying Notes | Equity_Instrument 316,584    
[1] The notes are convertible to EMI Holdings, Inc. shares.
[2]

The notes are convertible to Emmaus Life Sciences, Inc. shares.